Search
Returning search results with filters:
Remove filter for
Last updated: September 2020
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 9 of 9 items.
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-30
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
AlertPublic advisory | 2020-09-30
All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
AlertPublic advisory | 2020-09-24
Unauthorized health products sold on Steroid Hub Canada website may pose serious health risks
AlertPublic advisory | 2020-09-18
Unauthorized products may pose serious health risks (September 16, 2020: Part 1)
AlertPublic advisory | 2020-09-16
Unauthorized products may pose serious health risks (September 16, 2020: Part 2)
AlertPublic advisory | 2020-09-16
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
AlertHealth professional risk communication | 2020-09-15
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-14
Hand Sanitizers and Children's Safety: What you need to know
AlertPublic advisory | 2020-09-04